Arkolith/Insider Trading/PALI/Form 4

Finley John David

CEO, CFO, Director, DirectorPALISADE BIO, INC. (PALI) · full profile →Form 4 · filed May 30, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 28, 2024Tax withholding(F)607$4.76$3K13K
May 28, 2024Tax withholding(F)959$4.76$5K12K
May 28, 2024Option exercise(M)3K—$013K
May 28, 2024Tax withholding(F)467$4.76$2K10K
May 28, 2024Option exercise(M)2K—$010K
May 28, 2024Option exercise(M)2K—$014K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 28, 2024Option exercise(M)2K——0
May 28, 2024Option exercise(M)3K——0
May 28, 2024Option exercise(M)2K——0

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-022037) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML